---
tags:
  - B316
title: Alternative Parkinson Medications
---
| Antiparkinsonian Agents | Indications and Therapeutic Effects                                              | Common Side Effects                                                                                                                    |
| ----------------------- | -------------------------------------------------------------------------------- | -------------------------------------------------------------------------------------------------------------------------------------- |
| **Levodopa**            | Most effective for symptomatic relief                                            | Dyskinesia after 5 to 10 years of treatment, On-off syndrome, nausea, vomiting, anorexia, hypotension, dystonia, dyskinesia, confusion |
| **Carbidopa**           | Improves Levodopa effectivity; prevents its metabolism before reaching the brain |                                                                                                                                        |

| Anticholinergic Agents            | Indications and Therapeutic Effects                    | Common Side Effects                                                                           |
| --------------------------------- | ------------------------------------------------------ | --------------------------------------------------------------------------------------------- |
| **Trihexyphenidyl hydrochloride** | Control of tremor in patients with early onset disease | Blurred vision, flushing, rash, constipation, urinary retention, and acute confusional states |
| **Benztropine mesylate**          | Counteract the action of acetylcholine                 | Contraindicated in patients with narrow-angle glaucoma                                        |

| Antiviral Agents             | Indications and Therapeutic Effects                                                           | Common Side Effects                                                                                                                                                                    |
| ---------------------------- | --------------------------------------------------------------------------------------------- | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
| **Amantadine hydrochloride** | Reduce rigidity, tremor, bradykinesia, and postural changes in early Parkinson's disease (PD) | Psychiatric disturbances (mood changes, confusion, depression, hallucinations), lower extremity edema, nausea, epigastric distress, urinary retention, headache, and visual impairment |

| Dopamine Agonists      | Indications and Therapeutic Effects                                                        | Common Side Effects                                                                          |
| ---------------------- | ------------------------------------------------------------------------------------------ | -------------------------------------------------------------------------------------------- |
| **Bromocriptine Mesylate** | Early PD as well as secondary drug therapy after carbidopa or levodopa loses effectiveness | Nausea, vomiting, diarrhea, lightheadedness, hypotension, impotence, and psychiatric effects |
| **Pergolide**              |                                                                                            |                                                                                              |

| Nonergot Derivatives     | Indications and Therapeutic Effects | Common Side Effects               |
| ------------------------ | ----------------------------------- | --------------------------------- |
| **Ropinirole hydrochloride** | Early stages of PD                  | May cause drowsiness or dizziness |
| **Pramipexole**              |                                     |                                   |

| Monoamine Oxidase-Inhibitors | Indications and Therapeutic Effects | Common Side Effects                                                                                        |
| ---------------------------- | ----------------------------------- | ---------------------------------------------------------------------------------------------------------- |
| **Selegiline**                   | Inhibit dopamine breakdown          | Agitation, dizziness, nausea, headache, rhinitis, back pain, stomatitis, orthostatic hypotension, insomnia |
| **Rasagiline**                   |                                     |                                                                                                            |

| Catechol-O-Methyltransferase Inhibitors | Indications and Therapeutic Effects                       | Common Side Effects                                                   |
| --------------------------------------- | --------------------------------------------------------- | --------------------------------------------------------------------- |
| **Entacapone**                              | Increase the duration of action of carbidopa or levodopa. | Abdominal pain, back pain, constipation, nausea, diarrhea, hematouria |
| **Tolcapone**                               | Reduce motor fluctuations in patients with advanced PD    |                                                                       |
